Osimertinib and crizotinib cardiotoxicity: are real-world studies the way forward?

H. Kobat, I. Elkonaissi, E. Foreman, M. O'Brien, S. Nabhani-Gebara

    Research output: Contribution to conferencePosterpeer-review

    Original languageEnglish
    DOIs
    Publication statusPublished - Sept 2021
    EventESMO Congress 2021 - Paris, France (held online)
    Duration: 16 Sept 202121 Sept 2021

    Conference

    ConferenceESMO Congress 2021
    Period16/09/2121/09/21

    Bibliographical note

    Note: An abstract of this paper was published in published in Annals of Oncology (2021) 32 (suppl_5) on page S982. It is abstract number 1248P.

    Keywords

    • Biological sciences

    Cite this